Thermo Fisher Scientific Inc. 

(Public, NYSE:TMO)   Watch this stock   
Find more results for TMO
Oct 22, 2009
Q3 2009 Earnings Release
Sep 21, 2009
UBS Global Life Sciences Conference Breakout Session
Sep 21, 2009
UBS Global Life Sciences Conference - Webcast
Sep 14, 2009
Morgan Stanley Global Healthcare Conference - Webcast
Sep 11, 2009
Thomas Weisel Partners Healthcare Conference - Webcast
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 8.74% 9.42%
Operating margin 10.88% 11.71%
EBITD margin - 19.26%
Return on average assets 4.17% 4.67%
Return on average equity 5.82% 6.72%
Employees 34,000 -

Address

81 Wyman Street P.O. Box 9046
Waltham, MA 02454
United States - Map
+1-781-6221000 (Phone)
+1-781-6221123 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Thermo Fisher Scientific Inc. discussed on blogs

Ranking All U.S. Stocks by Weekly Performance - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - 5 hours ago
US hot stocks for next week - Nanometrics Incorporated, Melco ... - AC Investor Blog - AC Investor Blog - 10 hours ago
Bespoke Investment Group: S&P 500 Stocks With the Highest ... - Paul Hickey - Bespoke Investment Group - Nov 20, 2009

Thermo Fisher Scientific Inc. discussions

  View all discussions »

Description

Thermo Fisher Scientific Inc. (Thermo Fisher), incorporated in 1956, is engaged in serving science. It provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The Company operates through two segments: analytical technologies and laboratory products and services. Analytical technologies segment includes pharmaceutical, biotechnology, academic, government and other research and industrial markets. Laboratory products and services segment offers combination of products and services that allows its customers to engage in their core business functions of research, development, manufacturing, clinical diagnosis and drug discovery. In April 2009, Alesco Corporation Ltd. sold its Scientific & Medical division to Thermo Fisher Scientific Inc. In October 2009, the Company acquired B.R.A.H.M.S. AG.

Officers and directors

Jim P. Manzi
Chairman of the Board
Age: 57
Bio & Compensation - Reuters
Marc N. Casper
President, Chief Executive Officer, Director
Age: 41
Bio & Compensation - Reuters
Peter M. Wilver
Chief Financial Officer, Senior Vice President
Age: 49
Bio & Compensation - Reuters
Seth H. Hoogasian
Senior Vice President, General Counsel, Secretary
Age: 54
Bio & Compensation - Reuters
Stephen G. Sheehan
Senior Vice President - Human Resources
Age: 53
Bio & Compensation - Reuters
Alan J. Malus
Senior Vice President, President - Laboratory Products and Services
Age: 49
Bio & Compensation - Reuters
Edward A. Pesicka
Senior Vice President, President - Customer Channels
Age: 41
Bio & Compensation - Reuters
Gregory J. Herrema
Senior Vice President, President-Analytical Instruments
Age: 43
Bio & Compensation - Reuters
Yuh-geng Tsay
Senior Vice President, President - Specialty Diagnostics
Age: 60
Bio & Compensation - Reuters
Peter E. Hornstra
Vice President, Chief Accounting Officer
Age: 49
Bio & Compensation - Reuters